Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H., Hadaschik, B., . . . Zechmann, C. (2013). Reply to Reske et al: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer : biodistribution in humans and first evaluation of tumour lesions. European journal of nuclear medicine, 40(6), . https://doi.org/10.1007/s00259-013-2386-y
Chicago-Zitierstil (17. Ausg.)Afshar-Oromieh, Ali, et al. "Reply to Reske Et Al: PET Imaging with a [68Ga]gallium-labelled PSMA Ligand for the Diagnosis of Prostate Cancer : Biodistribution in Humans and First Evaluation of Tumour Lesions." European Journal of Nuclear Medicine 40, no. 6 (2013). https://doi.org/10.1007/s00259-013-2386-y.
MLA-Zitierstil (9. Ausg.)Afshar-Oromieh, Ali, et al. "Reply to Reske Et Al: PET Imaging with a [68Ga]gallium-labelled PSMA Ligand for the Diagnosis of Prostate Cancer : Biodistribution in Humans and First Evaluation of Tumour Lesions." European Journal of Nuclear Medicine, vol. 40, no. 6, 2013, https://doi.org/10.1007/s00259-013-2386-y.